DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Visser WH, Winner P, Strohmaier K. et al.
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Headache 2004; 44: 891-899
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.